A detailed history of Artemis Investment Management LLP transactions in Exact Sciences Corp stock. As of the latest transaction made, Artemis Investment Management LLP holds 106,775 shares of EXAS stock, worth $6.34 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
106,775
Holding current value
$6.34 Million
% of portfolio
0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$42.43 - $70.83 $4.53 Million - $7.56 Million
106,775 New
106,775 $7.27 Million
Q1 2021

Apr 28, 2021

SELL
$116.57 - $155.01 $8.34 Million - $11.1 Million
-71,504 Closed
0 $0
Q4 2020

Jan 26, 2021

BUY
$99.61 - $142.12 $272,532 - $388,840
2,736 Added 3.98%
71,504 $9.49 Million
Q3 2020

Oct 29, 2020

SELL
$72.92 - $102.01 $3.43 Million - $4.79 Million
-46,980 Reduced 40.59%
68,768 $7.01 Million
Q1 2020

Apr 14, 2020

SELL
$37.9 - $104.44 $1.2 Million - $3.32 Million
-31,781 Reduced 21.54%
115,748 $6.56 Million
Q4 2019

Jan 14, 2020

SELL
$77.66 - $99.74 $151,126 - $194,094
-1,946 Reduced 1.3%
147,529 $13.3 Million
Q3 2019

Oct 10, 2019

SELL
$90.37 - $122.49 $10.3 Million - $13.9 Million
-113,772 Reduced 43.22%
149,475 $13.2 Million
Q2 2019

Jul 24, 2019

SELL
$89.51 - $118.04 $725,568 - $956,832
-8,106 Reduced 2.99%
263,247 $30.5 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $10.6 Million - $16.5 Million
170,958 Added 170.29%
271,353 $23.5 Million
Q4 2018

Feb 12, 2019

SELL
$56.04 - $82.66 $2.7 Million - $3.99 Million
-48,233 Reduced 32.45%
100,395 $6.34 Million
Q3 2018

Nov 09, 2018

SELL
$48.29 - $80.6 $3.74 Million - $6.24 Million
-77,419 Reduced 34.25%
148,628 $11.7 Million
Q2 2018

Aug 08, 2018

BUY
$37.84 - $69.96 $8.55 Million - $15.8 Million
226,047 New
226,047 $13.5 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.